Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)

Stanford University

Status: Invitation-only

Conditions: Type 1 Diabetes

Treatments: Other: Integration with Epic

Study type: Interventional

Funder types: Other

Identifiers

NCT03968055

48935

Details and patient eligibility

About

To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.

Full description

Based on alerts from GluVue, care team members will proactively reach out to patients and their families for more frequent dose adjustments. We will assess if remote monitoring facilitates contact between the care team and patients and improves glycemic control.

Enrollment: 100 estimated patients

Sex: All

Ages: 6 months to 21 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
• Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
• Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring
• Age: birth to < 21 years of age

Exclusion criteria

• Diabetes diagnosis other than T1D
• Diagnosis of diabetes > 1 month prior to initial visit
• Individuals with the intention of obtaining diabetes care at another clinic
• Individuals who do not consent to CGM use, CGM data integration, or remote monitoring
• Individuals > 21 years of age

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Sequential Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Patients with Type 1 Diabetes

Other group

Description:

Participants will wear a continuous glucose monitor (CGM) and receive remote monitoring of the CGM data by the clinical care team.

Treatment:

Other: Integration with Epic